New horizon of cancer vaccine therapy using dendritic cells made from pluripotent pluripotent stem cells

Fukumi Furukawa

Article ID: 625
Vol 2, Issue 1, 2018

VIEWS - 744 (Abstract) 407 (PDF)

Full Text:

PDF


References


1. Kitadani J, Ojima T, Iwamoto H, et al. Cancer vaccine therapy using carcinoembryonic antigen-expressing dendritic cells generated from induced pluripotent stem cells. Sci Rep 2018; 8(1): 4569. doi: 10.1038/s41598-018-23120-z.

2. Katsuda M, Yamaue H. Cancer vaccine therapy based on peptides. Trends Immunother 2017; 1 (1): 10–18. doi: 10.24294/ti.v1.i1.41.

3. Galati D, Zanotta S. Hematologic neoplasms: dendritic cells vaccines in motion. Clin Immunol 2017; 183: 181–190. doi: 10.1016/j.clim.2017.08.016.

4. Tsunoda T, Shimada K, Uchida N, et al. Dynamic relationships among tumor, immune response, and microbiota. Trends Immunother 2017; 1(2): 58–66. doi: 10.24294/ti.v1.i2.79.




DOI: https://doi.org/10.24294/ti.v2.i1.625

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Fukumi Furukawa

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This site is licensed under a Creative Commons Attribution 4.0 International License.